Showing results (181-190 of 650) with videos related to
Sort By:
Pageof 65
Proceedings of the National Academy of Sciences of the United States of America|November 3, 2020
The role of "spillover" in antibiotic resistanceScott W Olesen, Marc Lipsitch, Yonatan H GradPhilosophical Transactions of the Royal Society of London. Series B, Biological Sciences|April 29, 2015
How could preventive therapy affect the prevalence of drug resistance? Causes and consequencesAmber Kunkel, Caroline Colijn, Marc Lipsitch, et al.Plos Genetics|March 11, 2011
Prevalence of epistasis in the evolution of influenza A surface proteinsSergey Kryazhimskiy, Jonathan Dushoff, Georgii A Bazykin, et al.Nature Ecology & Evolution|October 10, 2022
Mito-nuclear selection induces a trade-off between species ecological dominance and evolutionary lifespanDébora Princepe, Marcus A M de Aguiar, Joshua B PlotkinAmerican Journal of Epidemiology|November 17, 2011
Secular trends in Helicobacter pylori seroprevalence in adults in the United States: evidence for sustained race/ethnic disparitiesYonatan H Grad, Marc Lipsitch, Allison E AielloJournal of the Royal Society, Interface|June 22, 2018
The evolution of antibiotic resistance in a structured host populationFrançois Blanquart, Sonja Lehtinen, Marc Lipsitch, et al.American Journal of Epidemiology|November 18, 2017
Shared Genomic Variants: Identification of Transmission Routes Using Pathogen Deep-Sequence DataColin J Worby, Marc Lipsitch, William P HanageStatistics in Medicine|December 27, 2019
Novel methods for the analysis of stepped wedge cluster randomized trialsLee Kennedy-Shaffer, Victor de Gruttola, Marc LipsitchInfection and Immunity|September 24, 2005
Antibodies to conserved pneumococcal antigens correlate with, but are not required for, protection against pneumococcal colonization induced by prior exposure in a mouse modelKrzysztof Trzcinski, Claudette Thompson, Richard Malley, et al.Clinical Trials (London, England)|January 30, 2018
Impact of stochastically generated heterogeneity in hazard rates on individually randomized vaccine efficacy trialsRebecca Kahn, Matt Hitchings, Steven Bellan, et al.Pageof 65